21 January 2025 in Journal of Vascular and Interventional Radiology
To evaluate the feasibility and accuracy of a robotic device used clinically in soft tissues (abdomen and lung), modified in design and workflow, to perform needle insertion in percutaneous bone procedures. The primary objective was safety (severe complications) of robotic-assisted insertion in this new application. Secondary objectives were feasibility (placement technical success), performance (acceptable insertions rate), accuracy (lateral deviation), number of intermediate CT-scans and tolerance (minor/moderate complications). Robotic-assisted insertions were performed by six interventional radiologists on three male pigs under general anaesthesia. Needle trajectory was planned on the device software, then needles were inserted with robotic guidance to reach the cortical bone; an intermediate CT-scan was then performed to verify needle direction; if needed, the trajectory was modified, and robotic-assisted modified insertion to target was performed. As many intermediate CT scans and trajectory modifications as needed by the operator were allowed. 28 needles were inserted (10 spine, 18 pelvis). No complication was reported. Technical success rate was 96.4% (27/28). One insertion was not feasible after several robotic attempts. The placement success rate was 100% (27/27). After the planned intermediate CT-scan, 13/27 (48.1%) trajectories did not require any modification, and 11/27 trajectories (40.7%) required a single modification. One needle was removed and replaced to achieve correct placement. Placement accuracy was similar for spinal and pelvic insertions, with a mean lateral deviation of 2.1 mm (±1.3). Pre-clinical robotic-assisted needle insertions in bone were safe and feasible, with satisfactory accuracy. A multicentre first-in-human study is on-going to evaluate feasibility and safety for percutaneous bone ablation and consolidation procedures.